Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients

Clinical Chemistry

Volumn 48, Issue 10, 2002, Pages 1835-1843

  Qu, Yinsheng ^a   Adam, Bao Ling ^a   Yasui, Yutaka ^a   Ward, Michael D ^a   Cazares, Lisa H ^a   Schellhammer, Paul F ^a   Feng, Ziding ^a   Semmes, O John ^a   Wright Jr , George L ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROSTATE SPECIFIC ANTIGEN;

ADULT; ANTIGEN EXPRESSION; BIOINFORMATICS; CANCER DIAGNOSIS; CLINICAL TRIAL; COMPUTER ANALYSIS; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION THEORY; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PROSTATE CANCER; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; SERUM; SURFACE ENHANCED LASER DESORPTION IONIZATION MASS SPECTRAL;

EID: 0036791428     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.10.1835     Document Type: Conference Paper

References (20)

1. Stamey TA, Johnstone IM, McNeat JE, Lu AY, Yemoto CM. Preoperative serum prostate specific antigen levels between 2 and 22 ng/ml correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng/ml. J Urol 2002;167:103-11.
2. Merchant M, Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 2000;21:1164-77.
3. Kuwata H, Yip TT, Yip CL, Tomita M, Hutchens TW. Bactericidal domain of lactoferrin: detection, quantitation and characterization of lactoferricin in serum by SELDI affinity mass spectrometry. Biochem Biophys Res Comm 1998;245:764-73.
4. Wright GL Jr, Cazares LH, Leung S-M, Nasim S, Adam BL, Yip TT, et al. ProteinChip surface enhanced laser desorption/ionization (SELDI mass spectrometry: a novel proteomic technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer Prostate Dis 1999;2:264-7.
5. Vlahou A, Schellhammer PF, Mendrinos S, Patel K, Kondylis FI, Gong L, et al. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am J Pathol 2001;158:1491-502.
6. Pepe MS. Receiver operating characteristic methodology. J Am Stat Assoc 2000;95:308-11.
7. Freund Y, Schapire R. A decision-theoretical generalization of on-line learning and an application to boosting. J Computer Syst Sci 1997;55:119-39.
8. Hastie T, Tibshirani R, Friedman J. The elements of statistical learning. New York: Springer-Verlag, 2001:301pp.
9. Friedman J, Hastie T, Tibshirani R. Additive logistic regression: a statistical view of boosting. Ann Stat 2000;28:337-407.
10. Das S. Filters, wrappers and a boosting-based hybrid for feature selection. In: Brodley CE, Danyluk AP, eds. Proceeding of the Eighteenth International Conferences on Machine Learning. San Francisco, CA: Morgan Kaufmann Publishers, 2001:74-81.
11. Qu Y, Adam B-L, Thornquist M, Potter J, Yasui Y, Davis J, et al. Data reduction using discrete wavelet transform in discriminant analysis with very high dimension. Biometrics 2002;in press.
12. Yasui Y, Pepe M, Thompson ML, Adam BL, Wright G Jr, Qu Y, et al. A data-analytic strategy for protein-biomarker discovery: profiling of high-dimensional proteomic data for cancer detection. Technical Report No. 177. Seattle, WA: University of Washington, Department of Biostatistics, 2001.
13. Breiman L, Friedman JH, Olsen RA, Stone CJ. Classification and regression trees. Belmont, CA: Wadsworth International Group, 1984:203-15.
14. Adam B-L, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 2002;62:3609-14.
15. Drucker H, Cortes C. Boosting decision trees. Adv Neural Inf Process Syst 1996;8:479-85.
16. Schapire R, Freund Y. Boosting the margin: a new explanation for the electiveness of voting methods. Ann Stat 1998;26:1651-86.
17. Breiman L. Bagging predictors. Machine Learning 1996;26:123-40.
18. Breiman L. Statistical modeling: the two cultures. Stat Sci 2001; 16:199-231.
19. Petricoin EF III, Ardkani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002;359:572-7.
20. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan D. Potential serum biomarkers identified by SELDI mass spectrometry can discriminate breast cancer from non-cancer patients [Abstract]. Proc Am Assoc Cancer Res 2002;43:136.